Analytical solutions for mRNA vaccines andtherapeutics
Messenger RNA (mRNA) therapy enables the body to make the proteins we need to prevent, treat, or cure diseases. Unlike traditional biologics, mRNAs are large and delicate molecules that are produced using in vitro transcription (IVT), which need to be protected by lipid nanoparticles (LNPs) before they reach target cells. Analytical characterization of mRNA therapeutics presents unique challenges that require new technologies and solutions.
White Paper from 
If your Download does not start Automatically, Click Download Whitepaper